Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

216 * Mon, 7/31/2017, 2:00 PM - 3:50 PM CC-328
Statistical Opportunities in Disease Interception: Screening, Intervening, and Evaluating Benefit-Risk Trade-Offs — Topic Contributed Papers
Section on Medical Devices and Diagnostics , Section on Statistics in Epidemiology , Section on Risk Analysis
Organizer(s): Rachael L. DiSantostefano, Janssen R&D
Chair(s): Bennett Levitan, Janssen R&D
2:05 PM A Risk Stratification Approach for Improved Interpretation of Diagnostic Accuracy Statistics Hormuzd Katki, National Cancer Institute ; Mark Schiffman, National Cancer Institute
2:25 PM Personalizing Early Detection for Ovarian Cancer with Hierarchical Longitudinal Models of a Blood Biomarker: Experience in Multiple Prospective Screening Trials Steven Skates, MGH/Biostatistics Center
2:45 PM Personalizing Early Detection for Alzheimer's Disease: Biomarker Assessment in the Absence of a Gold Standard Zheyu Wang, Johns Hopkins University ; Yanxun Xu, Johns Hopkins University ; Marilyn Albert, Johns Hopkins University
3:05 PM Alzheimer's Intervention Case Study: Patient Preferences and Benefit-Risk Tradeoffs in Interception of Alzheimer's Disease Rachael L. DiSantostefano, Janssen R&D ; Shelby Reed, Duke University ; Reed Johnson, Duke University ; Jui-Chen Yang, Duke University ; Johannes Streffer, Janssen R&D ; Bennett Levitan, Janssen R&D
3:25 PM Evaluating Risk Prediction Tests to Guide Decisions on Prophylactic Treatment Gene Pennello, Food and Drug Administration ; Robert L Becker, Food and Drug Administration
3:45 PM Floor Discussion
Copyright © American Statistical Association